ciglitazone has been researched along with niflumic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, SH; Kim, BM; Lee, KH; Maeng, K | 1 |
1 other study(ies) available for ciglitazone and niflumic acid
Article | Year |
---|---|
Combined treatment with the Cox-2 inhibitor niflumic acid and PPARĪ³ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspase 8; Cell Line, Tumor; Cell Separation; Cyclooxygenase 2; Drug Synergism; Endoplasmic Reticulum; Flow Cytometry; Humans; Ligands; Lung Neoplasms; Niflumic Acid; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Transfection | 2011 |